Status:
COMPLETED
Pressure Injuries' Prevention in Newborn Infants Admitted to NICU
Lead Sponsor:
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Conditions:
Newborn
Pressure Injury
Eligibility:
All Genders
Up to 6 years
Phase:
NA
Brief Summary
Nasal Continuous Positive Airway Pressure (NCPAP) is a respiratory support for neonates with Respiratory Distress Syndrome (RDS) and represents the gold standard for RDS treatment in many Neonatal Int...
Detailed Description
Previous studies highlighted that nasal trauma, due to NCPAP support, is caused by the following risk factors: * Very Low birth weight (\< 1500 g) * Gestational age \< 32 weeks * NCPAP duration \> 5 ...
Eligibility Criteria
Inclusion
- Informed consent signed from both parents or legally authorized representative
- Infants receiving noninvasive respiratory support with Nasal Continuous Positive Airway Pressure (NCPAP) or Synchronized Nasal Intermittent Positive Pressure Ventilation (SNIPPV)
Exclusion
- Pre-existing nasal lesion
Key Trial Info
Start Date :
December 2 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 16 2022
Estimated Enrollment :
280 Patients enrolled
Trial Details
Trial ID
NCT04293601
Start Date
December 2 2019
End Date
May 16 2022
Last Update
May 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NICU, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, Italy, 20122